The Value and Institutional Impact of an In-System Laboratory Testing During the COVID-19 Pandemic. (29th April 2021)

• Record Type: Journal Article
• Authors: Kaul, Karen; Singh, Kamaljit; Sabatini, Linda; Konchak, Chad; McElvania, Erin; Larkin, Paige; Lindgren, Rebecca; Sutherland, Christina; Granchalek, Gustav; Herrada, Alfredo; Murray, Brian; Charles, E Matt; Dugad, Priya; Livschiz, Ekaterina
• Is Part Of: Academic pathology. Volume 8(2021:Jan./Dec.)
• Publication Date: 2021-04-29
• Subjects: COVID-19 -- cost avoidance -- finance -- laboratory testing -- polymerase chain reaction -- revenue; Pathology -- Study and teaching (Higher) -- North America -- Periodicals; Pathology; Periodicals; 616.0707117
• DOI: 10.1177/23742895211010253
• Languages: English
• ISSNs: 2374-2895

Abstract

In-system clinical laboratories have proven themselves to be a fundamentally important resource to their institutions during the COVID-19 pandemic of the past year. The ability to provide SARS-CoV-2 molecular testing to our hospital system allowed us to offer the best possible care to our patients, and to support neighboring hospitals and nursing homes. In-house testing led to significant revenue enhancement to the laboratory and institution, and attracted new patients to the system. Timely testing of inpatients allowed the majority who did not have COVID-19 infection to be removed from respiratory and contact isolation, conserving valuable personal protective equipment and staff resources at a time that both were in short supply. As 2020 evolved and our institution restarted delivery of routine care, the availability of in-system laboratory testing to deliver both accurate and timely results was absolutely critical. In this article, we attempt to demonstrate the value and impact of an in-system laboratory during the COVID-19 pandemic. A strong in-house laboratory service was absolutely critical to institutional operational and financial success during 2020, and will ensure resiliency in the future as well.